Skip to Content


In the US, Melphalan (melphalan systemic) is a member of the drug class alkylating agents and is used to treat Multiple Myeloma and Ovarian Cancer.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Cytostatic alkylating agent

Chemical Name

L-Phenylalanine, 4-[bis(2-chloroetyl)amino]-

Foreign Names

  • Melphalanum (Latin)
  • Melphalan (German)
  • Melphalan (French)
  • Melfalán (Spanish)

Generic Names

  • Melfalan (OS: DCIT)
  • Melphalan (OS: USAN, JAN, DCF, BAN)
  • CB 3025 (IS)
  • L-PAM (IS)
  • Phenylalanin-Lost (IS)
  • SK 15673 (IS)
  • Melphalan (PH: BP 2016, JP XVI, Ph. Eur. 8, USP 38)
  • Melphalanum (PH: Ph. Eur. 8)

Brand Names

  • Alkeran
    ApoPharma, United States; Aspen, Australia; Aspen, Belgium; Aspen, Switzerland; Aspen, Denmark; Aspen, Estonia; Aspen, Ireland; Aspen, Iceland; Aspen, Malaysia; Aspen, New Zealand; Aspen, Poland; Aspen, Slovakia; Aspen Labs, Mexico; Aspen Pharma, Germany; Aspen Pharma, Norway; Aspen Pharma Trading, Austria; Aspen Pharmacare, Hong Kong; Aspen Pharmacare, South Africa; Aspri Pharma, Canada; Glaxo Smithkline, Lebanon; Glaxo Wellcome, Romania; GlaxoSmithKline, Brazil; GlaxoSmithKline, China; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Egypt; GlaxoSmithKline, Indonesia; GlaxoSmithKline, Israel; GlaxoSmithKline, India; GlaxoSmithKline, Japan; GlaxoSmithKline, Kenya; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Oman; GlaxoSmithKline, Philippines; GlaxoSmithKline, Taiwan; LENIS, Slovenia; Navamedic, Finland; Vitaflo, Sweden; VLD, Turkey; Wellcome-GB, Italy
  • Alkéran
    HAC Pharma, France
  • Alkeran Valeant
    Valeant, Latvia
  • Alkerana
    GlaxoSmithKline, Argentina
  • Eriolan
    Eriochem, Argentina
  • Melfalan Varifarma
    Varifarma, Argentina
  • Melfoma
    Dosa, Argentina
  • Melphalan Aspen
    Aspen, United Kingdom
  • Alkeran
    ApoPharma, United States; Aspen, Estonia; Aspen, Malaysia; Aspen, Netherlands; Aspen, New Zealand; Euro Registratie, Netherlands; GlaxoSmithKline, Lithuania; Pharmatech Chile, Chile; Vitaflo, Sweden
  • Melfalan Aspen
    Aspen, Spain
  • Melfalan GlaxoSmithKline
    GlaxoSmithKline, Spain
  • Melphalan Aspen
    Aspen, United Kingdom
  • Melphalan Hydrochloride Bioniche
    Bioniche, United States


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.